Orphazyme A/S

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DK0062502894
DKK
730.00
-20 (-2.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Orphazyme A/S Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
0.00
-26.00
-41.00
-83.00
-635.00
-342.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-3.00
0.00
-3.00
0.00
42.00
2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-3.00
-20.00
-104.00
-602.00
-539.00
-326.00
Cash Flow from Investing Activities
-9.00
-6.00
90.00
0.00
-5.00
-3.00
Cash Flow from Financing Activities
5.00
0.00
-35.00
-30.00
1,159.00
58.00
Net Cash Inflow / Outflow
-7.00
-27.00
-48.00
-624.00
603.00
-271.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
8.00
-11.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in DKK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Orphazyme A/S
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(DKK)
Change(%)
Profit Before Tax
-0.298
971.357
-971.00
-100.03%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-3.422
176.914
-179.00
-101.93%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-3.361
1949.832
-1,952.00
-100.17%
Cash Flow from Investing Activities
-9.327
-1870.863
1,861.00
99.50%
Cash Flow from Financing Activities
5.306
55.775
-50.00
-90.49%
Net Cash Inflow / Outflow
-7.383
146.256
-153.00
-105.05%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.001
11.512
-11.00
-100.01%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 83.21% vs 80.84% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-3.36
-20.02
83.21%